Al-Rabi Tawil
Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Muscular Dystrophy, Facioscapulohumeral | 10 | 2001 | 8 |
Why?
| Muscular Dystrophies | 15 | 1993 | 28 |
Why?
| Paralyses, Familial Periodic | 9 | 1991 | 7 |
Why?
| Chromosomes, Human, Pair 4 | 10 | 1993 | 14 |
Why?
| Myositis, Inclusion Body | 4 | 2001 | 7 |
Why?
| Mutation | 14 | 1991 | 340 |
Why?
| Interferon-beta | 3 | 2001 | 26 |
Why?
| Genetic Linkage | 6 | 1992 | 57 |
Why?
| Potassium Channels, Inwardly Rectifying | 6 | 2001 | 7 |
Why?
| Muscle, Skeletal | 9 | 2003 | 114 |
Why?
| Acetazolamide | 3 | 1993 | 14 |
Why?
| Sodium Channels | 8 | 1991 | 32 |
Why?
| Andersen Syndrome | 2 | 2005 | 1 |
Why?
| Potassium | 4 | 1994 | 98 |
Why?
| Paralysis | 5 | 1993 | 37 |
Why?
| Adult | 31 | 1993 | 1317 |
Why?
| Humans | 55 | 1991 | 1856 |
Why?
| Neuromuscular Diseases | 3 | 1995 | 26 |
Why?
| Hypokalemic Periodic Paralysis | 2 | 2004 | 2 |
Why?
| Genetic Predisposition to Disease | 3 | 2003 | 131 |
Why?
| Male | 43 | 1983 | 1553 |
Why?
| Birth Injuries | 1 | 2006 | 4 |
Why?
| Adolescent | 16 | 1993 | 891 |
Why?
| Gene Deletion | 4 | 1996 | 121 |
Why?
| Retinal Diseases | 1 | 2006 | 22 |
Why?
| Carbonic Anhydrase Inhibitors | 2 | 2004 | 8 |
Why?
| Middle Aged | 24 | 1993 | 1161 |
Why?
| Female | 36 | 1992 | 1643 |
Why?
| Twins, Monozygotic | 3 | 1993 | 28 |
Why?
| Adrenergic beta-Agonists | 3 | 1998 | 39 |
Why?
| Pregnancy Complications | 1 | 2006 | 98 |
Why?
| Shoulder | 3 | 1994 | 15 |
Why?
| Face | 3 | 1995 | 25 |
Why?
| Diseases in Twins | 2 | 1993 | 30 |
Why?
| Albuterol | 2 | 1998 | 15 |
Why?
| Body Weight | 2 | 1998 | 178 |
Why?
| Chromosome Mapping | 6 | 1992 | 107 |
Why?
| Body Composition | 2 | 1997 | 44 |
Why?
| Adjuvants, Immunologic | 1 | 2001 | 73 |
Why?
| Thinness | 1 | 2000 | 12 |
Why?
| Dichlorphenamide | 1 | 2000 | 3 |
Why?
| Long QT Syndrome | 2 | 2002 | 35 |
Why?
| Phenotype | 11 | 1993 | 303 |
Why?
| DNA Mutational Analysis | 5 | 1999 | 110 |
Why?
| Pilot Projects | 4 | 1997 | 264 |
Why?
| Pedigree | 9 | 1992 | 84 |
Why?
| Double-Blind Method | 5 | 2000 | 274 |
Why?
| Genotype | 9 | 1995 | 175 |
Why?
| DNA Methylation | 2 | 2006 | 29 |
Why?
| Gene Expression Regulation | 4 | 2004 | 277 |
Why?
| Arm | 1 | 1997 | 48 |
Why?
| Hypokalemia | 4 | 1994 | 14 |
Why?
| Aged | 8 | 1993 | 988 |
Why?
| Obesity | 1 | 2000 | 149 |
Why?
| Gene Therapy | 1 | 1999 | 89 |
Why?
| Arrhythmias, Cardiac | 3 | 2001 | 65 |
Why?
| Prednisone | 1 | 1997 | 80 |
Why?
| Treatment Outcome | 6 | 1997 | 661 |
Why?
| Child | 8 | 1993 | 749 |
Why?
| Heart | 2 | 2002 | 88 |
Why?
| Sex Factors | 2 | 2002 | 284 |
Why?
| Gene Rearrangement | 1 | 1993 | 26 |
Why?
| Muscles | 5 | 1991 | 111 |
Why?
| Point Mutation | 3 | 1996 | 122 |
Why?
| Muscle Weakness | 3 | 2003 | 25 |
Why?
| Tachycardia, Ventricular | 1 | 1994 | 25 |
Why?
| Gene Expression Profiling | 2 | 2003 | 138 |
Why?
| Kidney Calculi | 1 | 1993 | 20 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2003 | 135 |
Why?
| Myostatin | 2 | 2006 | 3 |
Why?
| Hyperkalemia | 3 | 1991 | 20 |
Why?
| Animals | 10 | 1983 | 1031 |
Why?
| Syndrome | 3 | 1994 | 142 |
Why?
| Genetic Testing | 2 | 2006 | 49 |
Why?
| Absorptiometry, Photon | 2 | 1998 | 26 |
Why?
| Myotonia Congenita | 3 | 1992 | 7 |
Why?
| Abnormalities, Multiple | 2 | 1994 | 40 |
Why?
| Disease Models, Animal | 2 | 1998 | 349 |
Why?
| Severity of Illness Index | 2 | 1996 | 358 |
Why?
| Comorbidity | 2 | 2006 | 190 |
Why?
| Tandem Repeat Sequences | 1 | 2008 | 8 |
Why?
| Deoxyribonuclease I | 1 | 2008 | 16 |
Why?
| Genes, Dominant | 2 | 1993 | 68 |
Why?
| Drug Eruptions | 1 | 2008 | 26 |
Why?
| Epigenesis, Genetic | 1 | 2008 | 11 |
Why?
| DNA, Neoplasm | 1 | 2008 | 75 |
Why?
| Spinal Muscular Atrophies of Childhood | 1 | 2007 | 6 |
Why?
| Disease Progression | 2 | 1997 | 244 |
Why?
| Prospective Studies | 3 | 1997 | 545 |
Why?
| Stem Cell Transplantation | 1 | 2008 | 50 |
Why?
| Genetic Markers | 4 | 1993 | 78 |
Why?
| Fetal Distress | 1 | 2006 | 6 |
Why?
| Antibodies | 1 | 2008 | 159 |
Why?
| Retinal Artery | 1 | 2006 | 12 |
Why?
| Chromatin | 1 | 2008 | 29 |
Why?
| Extremities | 1 | 1997 | 32 |
Why?
| Disability Evaluation | 1 | 2007 | 61 |
Why?
| Infant, Low Birth Weight | 1 | 2006 | 31 |
Why?
| Infection | 1 | 2006 | 57 |
Why?
| Calcium Channels | 3 | 1994 | 52 |
Why?
| Molecular Biology | 1 | 2006 | 38 |
Why?
| Cesarean Section | 1 | 2006 | 41 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2006 | 48 |
Why?
| Motor Activity | 1 | 2007 | 104 |
Why?
| Iron Metabolism Disorders | 1 | 2005 | 2 |
Why?
| Dermatomyositis | 1 | 2005 | 16 |
Why?
| Paralysis, Hyperkalemic Periodic | 1 | 2004 | 2 |
Why?
| Ferritins | 1 | 2005 | 36 |
Why?
| Physical Exertion | 1 | 2004 | 46 |
Why?
| Myotonic Disorders | 1 | 2004 | 9 |
Why?
| Interferon-alpha | 1 | 2005 | 43 |
Why?
| Muscle Proteins | 2 | 1994 | 56 |
Why?
| Cross-Sectional Studies | 1 | 2006 | 253 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 1994 | 25 |
Why?
| Iron | 1 | 2005 | 75 |
Why?
| Lymphoid Tissue | 1 | 1994 | 34 |
Why?
| Trinucleotide Repeats | 1 | 2004 | 15 |
Why?
| Potassium Channels | 2 | 2001 | 33 |
Why?
| Drug Therapy, Combination | 1 | 2004 | 189 |
Why?
| Risk Assessment | 1 | 2008 | 324 |
Why?
| Transforming Growth Factor beta | 1 | 2006 | 99 |
Why?
| Sensation | 1 | 1983 | 18 |
Why?
| Myoblasts | 1 | 2003 | 17 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2003 | 15 |
Why?
| Inferior Colliculi | 1 | 1983 | 11 |
Why?
| Palliative Care | 1 | 2004 | 65 |
Why?
| Predictive Value of Tests | 1 | 2005 | 321 |
Why?
| Synaptic Transmission | 1 | 1983 | 58 |
Why?
| Extracellular Matrix Proteins | 1 | 2003 | 45 |
Why?
| Rabbits | 2 | 1994 | 252 |
Why?
| Body Mass Index | 2 | 2000 | 122 |
Why?
| Ion Channel Gating | 2 | 1999 | 42 |
Why?
| Neopterin | 1 | 2001 | 4 |
Why?
| Heart Defects, Congenital | 1 | 2002 | 55 |
Why?
| Immune System | 1 | 2002 | 43 |
Why?
| Electrophysiology | 1 | 2002 | 101 |
Why?
| Facies | 1 | 2001 | 1 |
Why?
| Infant, Newborn | 1 | 2006 | 389 |
Why?
| Questionnaires | 1 | 2006 | 360 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2001 | 14 |
Why?
| Blotting, Southern | 3 | 1993 | 69 |
Why?
| Pregnancy | 1 | 2006 | 455 |
Why?
| Immunosuppressive Agents | 1 | 2002 | 102 |
Why?
| Aged, 80 and over | 2 | 1993 | 599 |
Why?
| Scintillation Counting | 1 | 2000 | 5 |
Why?
| Neoplasms | 1 | 2008 | 239 |
Why?
| Electrocardiography | 1 | 2005 | 132 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 1999 | 12 |
Why?
| Periodicity | 2 | 1994 | 28 |
Why?
| Oxidative Stress | 1 | 2003 | 119 |
Why?
| Anabolic Agents | 1 | 1999 | 7 |
Why?
| Scapula | 2 | 1995 | 9 |
Why?
| Humerus | 2 | 1995 | 11 |
Why?
| Human Growth Hormone | 1 | 1999 | 21 |
Why?
| Reference Values | 1 | 2000 | 278 |
Why?
| Muscular Dystrophy, Animal | 1 | 1998 | 5 |
Why?
| Regression Analysis | 1 | 2000 | 256 |
Why?
| Steroids | 1 | 1999 | 38 |
Why?
| Insulin-Like Growth Factor I | 1 | 1999 | 64 |
Why?
| Anti-Inflammatory Agents | 1 | 1999 | 80 |
Why?
| Time Factors | 2 | 2000 | 896 |
Why?
| Brain | 1 | 2005 | 305 |
Why?
| Polymorphism, Restriction Fragment Length | 2 | 1993 | 32 |
Why?
| Isometric Contraction | 2 | 1993 | 22 |
Why?
| Organ Size | 2 | 1997 | 118 |
Why?
| Thyrotoxicosis | 1 | 1996 | 4 |
Why?
| Triiodothyronine | 1 | 1996 | 23 |
Why?
| Prognosis | 1 | 2000 | 388 |
Why?
| Peroneal Nerve | 1 | 1995 | 5 |
Why?
| Muscle Fibers, Skeletal | 2 | 2005 | 21 |
Why?
| Molecular Sequence Data | 5 | 1991 | 404 |
Why?
| Amino Acid Sequence | 4 | 1991 | 319 |
Why?
| Physical Therapy Modalities | 1 | 1994 | 18 |
Why?
| Inclusion Bodies | 1 | 1994 | 20 |
Why?
| Muscular Diseases | 1 | 1994 | 36 |
Why?
| Facial Bones | 1 | 1994 | 21 |
Why?
| Family Health | 2 | 2001 | 69 |
Why?
| Brain Diseases | 1 | 1994 | 75 |
Why?
| Dementia | 1 | 1994 | 56 |
Why?
| Peripheral Nervous System Diseases | 1 | 1994 | 45 |
Why?
| Mice, Knockout | 2 | 2005 | 265 |
Why?
| Neuropsychological Tests | 1 | 1994 | 113 |
Why?
| Recombination, Genetic | 1 | 1993 | 78 |
Why?
| Genes | 1 | 1991 | 82 |
Why?
| Cell Line | 2 | 2003 | 375 |
Why?
| Immunohistochemistry | 2 | 2003 | 355 |
Why?
| Patch-Clamp Techniques | 2 | 1999 | 47 |
Why?
| Child, Preschool | 2 | 2004 | 554 |
Why?
| Reproducibility of Results | 2 | 1994 | 391 |
Why?
| DNA Primers | 2 | 1999 | 208 |
Why?
| G-Quadruplexes | 1 | 2008 | 1 |
Why?
| Placebo Effect | 1 | 2008 | 26 |
Why?
| Models, Biological | 1 | 1994 | 410 |
Why?
| Internationality | 1 | 2008 | 28 |
Why?
| Alleles | 2 | 1994 | 108 |
Why?
| Gene Dosage | 1 | 2007 | 24 |
Why?
| Gene Frequency | 1 | 2007 | 42 |
Why?
| Hypertrophy | 1 | 2006 | 46 |
Why?
| Fibrosis | 1 | 2006 | 46 |
Why?
| Polymerase Chain Reaction | 3 | 1991 | 279 |
Why?
| Chromosome Aberrations | 1 | 2007 | 45 |
Why?
| Tamoxifen | 1 | 2006 | 38 |
Why?
| Gene Expression | 2 | 1999 | 291 |
Why?
| Sequence Homology, Amino Acid | 2 | 1994 | 156 |
Why?
| Microscopy, Immunoelectron | 1 | 2005 | 22 |
Why?
| Lectins, C-Type | 1 | 2005 | 19 |
Why?
| Calcium Channels, L-Type | 2 | 1994 | 15 |
Why?
| Incidence | 1 | 2008 | 336 |
Why?
| Diet Therapy | 1 | 2005 | 12 |
Why?
| Antigens, CD3 | 1 | 2005 | 37 |
Why?
| Antigens, CD4 | 1 | 2005 | 29 |
Why?
| Receptors, Immunologic | 1 | 2005 | 36 |
Why?
| Copper | 1 | 2005 | 36 |
Why?
| Models, Animal | 1 | 2005 | 85 |
Why?
| Cohort Studies | 1 | 2008 | 332 |
Why?
| Hepatocytes | 1 | 2005 | 42 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2004 | 17 |
Why?
| Mice | 2 | 2005 | 623 |
Why?
| Immunosuppression | 1 | 1994 | 47 |
Why?
| Blood Vessels | 1 | 2005 | 65 |
Why?
| GTP-Binding Proteins | 1 | 2005 | 47 |
Why?
| Dendritic Cells | 1 | 2005 | 60 |
Why?
| Mechanoreceptors | 1 | 1983 | 9 |
Why?
| Evoked Potentials | 1 | 1983 | 44 |
Why?
| Cats | 1 | 1983 | 71 |
Why?
| Electric Stimulation | 1 | 1983 | 101 |
Why?
| Reaction Time | 1 | 1983 | 81 |
Why?
| Auditory Perception | 1 | 1983 | 25 |
Why?
| Biological Markers | 1 | 2005 | 262 |
Why?
| Neural Pathways | 1 | 1983 | 48 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 243 |
Why?
| Diagnosis, Differential | 1 | 2005 | 402 |
Why?
| Spinal Cord | 1 | 1983 | 94 |
Why?
| Biopsy | 1 | 2003 | 207 |
Why?
| Nerve Tissue Proteins | 1 | 2005 | 128 |
Why?
| Promoter Regions, Genetic | 1 | 2005 | 188 |
Why?
| Hand Strength | 1 | 2001 | 18 |
Why?
| Membrane Glycoproteins | 1 | 2005 | 154 |
Why?
| Visual Perception | 1 | 1983 | 51 |
Why?
| Follow-Up Studies | 1 | 1997 | 553 |
Why?
| Mice, Inbred C57BL | 1 | 2006 | 318 |
Why?
| Placebos | 1 | 2001 | 110 |
Why?
| Risk Factors | 1 | 2008 | 555 |
Why?
| Case-Control Studies | 1 | 2003 | 283 |
Why?
| Blotting, Western | 1 | 2003 | 275 |
Why?
| Skin | 1 | 1983 | 177 |
Why?
| Binding Sites | 1 | 2003 | 213 |
Why?
| Xenopus | 1 | 2001 | 37 |
Why?
| Mutation, Missense | 1 | 2001 | 59 |
Why?
| Clinical Trials as Topic | 1 | 1994 | 251 |
Why?
| Oocytes | 1 | 2001 | 45 |
Why?
| Base Sequence | 2 | 1994 | 371 |
Why?
| RNA, Messenger | 1 | 2006 | 394 |
Why?
| DNA | 2 | 1993 | 262 |
Why?
| Protein Structure, Tertiary | 1 | 1999 | 163 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 1997 | 23 |
Why?
| Neurons | 1 | 2005 | 195 |
Why?
| Kinetics | 1 | 1999 | 349 |
Why?
| Transfection | 1 | 1999 | 237 |
Why?
| Kidney | 1 | 1999 | 223 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 1994 | 19 |
Why?
| Autoradiography | 1 | 1994 | 73 |
Why?
| Cosmids | 1 | 1993 | 7 |
Why?
| Mosaicism | 1 | 1993 | 13 |
Why?
| Lod Score | 1 | 1993 | 17 |
Why?
| Clinical Protocols | 1 | 1994 | 93 |
Why?
| Biomechanics | 1 | 1994 | 79 |
Why?
| Polymorphism, Genetic | 1 | 1994 | 94 |
Why?
| Pain Measurement | 1 | 1994 | 98 |
Why?
| Cells, Cultured | 1 | 1999 | 447 |
Why?
| Models, Structural | 1 | 1991 | 42 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1991 | 88 |
Why?
| Nucleic Acid Conformation | 1 | 1994 | 56 |
Why?
| Protein Conformation | 1 | 1991 | 123 |
Why?
|
|
Tawil's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
